As of 2024-07-27, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 715.06 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1,078.63 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is -33.7%.
The range of the Relative Valuation is 609.97 - 748.52 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 21.4x | 20.7x |
| Forward P/E multiples | 17.6x - 21.6x | 20.4x |
| Fair Price | 609.97 - 748.52 | 715.06 |
| Upside | -43.4% - -30.6% | -33.7% |
| Date | P/E |
| 2024-07-26 | 30.81 |
| 2024-07-25 | 30.40 |
| 2024-07-24 | 30.30 |
| 2024-07-23 | 30.15 |
| 2024-07-22 | 30.55 |
| 2024-07-19 | 30.38 |
| 2024-07-18 | 30.48 |
| 2024-07-17 | 31.01 |
| 2024-07-16 | 31.28 |
| 2024-07-15 | 30.91 |
| 2024-07-12 | 31.42 |
| 2024-07-11 | 30.86 |
| 2024-07-10 | 30.59 |
| 2024-07-09 | 30.11 |
| 2024-07-08 | 30.06 |
| 2024-07-05 | 29.54 |
| 2024-07-03 | 29.25 |
| 2024-07-02 | 29.84 |
| 2024-07-01 | 30.19 |
| 2024-06-28 | 30.02 |
| 2024-06-27 | 30.02 |
| 2024-06-26 | 30.54 |
| 2024-06-25 | 30.60 |
| 2024-06-24 | 30.39 |
| 2024-06-21 | 30.08 |
| 2024-06-20 | 29.83 |
| 2024-06-18 | 29.68 |
| 2024-06-17 | 29.86 |
| 2024-06-14 | 29.61 |
| 2024-06-13 | 29.32 |
| 2024-06-12 | 29.35 |
| 2024-06-11 | 28.86 |
| 2024-06-10 | 28.61 |
| 2024-06-07 | 28.65 |
| 2024-06-06 | 28.59 |
| 2024-06-05 | 28.73 |
| 2024-06-04 | 28.37 |
| 2024-06-03 | 28.26 |
| 2024-05-31 | 28.00 |
| 2024-05-30 | 27.70 |
| 2024-05-29 | 27.61 |
| 2024-05-28 | 27.80 |
| 2024-05-24 | 28.14 |
| 2024-05-23 | 28.01 |
| 2024-05-22 | 28.10 |
| 2024-05-21 | 28.39 |
| 2024-05-20 | 28.20 |
| 2024-05-17 | 28.06 |
| 2024-05-16 | 27.65 |
| 2024-05-15 | 27.94 |